AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2790538 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Infusion (CI) of recombinant interleukin-2 (IL-2) at a maximum tolerated dose of 10(6) U/m2 per day for 7 days
Number of subjects: 25
Study 2790538 — intervention group
Group type: COMPARATOR
Intervention: Both BI and CI
Number of subjects: 25
Study 768911 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (mean dosage 10 mg/kg, maximum 22 mg/kg)
Number of subjects: 50
Study 31883082 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin transdermal patches (40-80 mg/day for 52 weeks)
Number of subjects: 223
Study 30641337 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAST-CH (ISPCAN Child Abuse Screening Tool – Child, Home Version)
Number of subjects: 6957
Study 29214923 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 43
Study 29214923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 43
Study 25046241 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitening toothpaste with enzymatic action (papain and bromelain)
Number of subjects: 90
Study 25046241 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitening toothpaste with abrasive action (perlite/calcium carbonate)
Number of subjects: 90
Study 23320780 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented bipolar implant (n=133)
Number of subjects: 261
Study 23320780 — intervention group
Group type: COMPARATOR
Intervention: Cemented unipolar head (n=128)
Number of subjects: 261
Study 22099239 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (classroom sessions to improve sun protection knowledge and attitudes towards hat use)
Number of subjects: 439
Study 22099239 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 439
Study 22099239 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (for subgroup of 439 students)
Number of subjects: 439
Study 17964826 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) treatment
Number of subjects: 26
Study 17964826 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LMWH treatment)
Number of subjects: 26
Study 16806420 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine infiltration
Number of subjects: 114
Study 16806420 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular diclofenac
Number of subjects: 114
Study 12928047 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of serum markers including interleukin‐6 (IL‐6) receptor, protein alpha1 fraction, cysteine, and cholesterol concentrations
Number of subjects: 0
Study 12928047 — intervention group
Group type: COMPARATOR
Intervention: Single serum markers
Number of subjects: 0
Study 11192361 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/Zok
Number of subjects: 3991
Study 11192361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3991
Study 9087161 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide nasal aerosol (220 micrograms, once daily for 6 weeks)
Number of subjects: 56
Study 9087161 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal aerosol (once daily for 6 weeks)
Number of subjects: 56
Study 8334542 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms fenoterol
Number of subjects: 12
Study 8334542 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms fenoterol
Number of subjects: 12
Study 8334542 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms fenoterol
Number of subjects: 12
Study 8334542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8334542 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 12
Study 2868173 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic regimens for preventing or treating wound sepsis
Number of subjects: 0
Study 2868173 — intervention group
Group type: EXPERIMENTAL
Intervention: ASEPSIS scoring method
Number of subjects: 0
Study 29762063 — intervention group
Group type: EXPERIMENTAL
Intervention: Human-controlled avatar
Number of subjects: 78
Study 29762063 — intervention group
Group type: COMPARATOR
Intervention: Computer-controlled agent
Number of subjects: 78
Study 29762063 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 78
Study 27723444 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 181
Study 27723444 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 181
Study 25314051 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC4 score
Number of subjects: 0
Study 25314051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammostrat score
Number of subjects: 0
Study 22982184 — intervention group
Group type: EXPERIMENTAL
Intervention: Teduglutide (0.05 mg/kg/d)
Number of subjects: 86
Study 22982184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 20484101 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitinol stent implantation
Number of subjects: 206
Study 20484101 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 206
Study 18820310 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 200
Study 18820310 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine injection
Number of subjects: 200
Study 18820310 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained GPs
Number of subjects: 200
Study 18820310 — intervention group
Group type: COMPARATOR
Intervention: Untrained GPs
Number of subjects: 200
Study 15198997 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 480
Study 15198997 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 480
Study 12509195 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-form correspondence instruction
Number of subjects: 200
Study 12509195 — intervention group
Group type: COMPARATOR
Intervention: Aesthetic-correspondence instruction
Number of subjects: 200
Study 10703128 — intervention group
Group type: EXPERIMENTAL
Intervention: Surodex (intraocular dexamethasone drug delivery system)
Number of subjects: 150
Study 10703128 — intervention group
Group type: COMPARATOR
Intervention: Placebo drug delivery system
Number of subjects: 150
Study 10703128 — intervention group
Group type: COMPARATOR
Intervention: Topical dexamethasone (eye drop therapy)
Number of subjects: 150
Study 8765813 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide (1 mg)
Number of subjects: 40
Study 8765813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1913699 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-458 (HPMC)
Number of subjects: 94
Study 1913699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 6789733 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily streptomycin, isoniazid, rifampin, and pyrazinamide for 2 months
Number of subjects: 1033
Study 6789733 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily streptomycin, isoniazid, rifampin, and pyrazinamide for 3 months
Number of subjects: 1033
Study 6789733 — intervention group
Group type: COMPARATOR
Intervention: 12-month control regimen
Number of subjects: 1033
Study 6789733 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective chemotherapy (treatment started only after active disease confirmation)
Number of subjects: 1033
Study 6789733 — intervention group
Group type: EXPERIMENTAL
Intervention: All initial cultures negative (short-course regimens)
Number of subjects: 1033
Study 31075954 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytochemicals (e.g., agaricus, curcumin, Neovastat)
Number of subjects: 0
Study 31075954 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytochemicals
Number of subjects: 0
Study 27824257 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived availability of offline social support
Number of subjects: 237
Study 27824257 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived family cohesion
Number of subjects: 237
Study 26094974 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 25 mg once daily
Number of subjects: 242
Study 26094974 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg once daily
Number of subjects: 242
Study 26094974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 25604111 — intervention group
Group type: EXPERIMENTAL
Intervention: Slight sedation (Richmond Agitation Sedation Score -1 to 0, n = 38)
Number of subjects: 78
Study 25604111 — intervention group
Group type: COMPARATOR
Intervention: Usual sedation (Richmond Agitation Sedation Score -3 to -2, n = 40)
Number of subjects: 78
Study 21890828 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen Online Problem-Solving (TOPS)
Number of subjects: 41
Study 21890828 — intervention group
Group type: COMPARATOR
Intervention: Internet resource comparison
Number of subjects: 41
Study 19805790 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention
Number of subjects: 1463
Study 19805790 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1463
Study 19805790 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits and subjective norms
Number of subjects: 1463
Study 17949807 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS02D
Number of subjects: 214
Study 17949807 — intervention group
Group type: COMPARATOR
Intervention: Engerix-B (hepatitis B vaccine)
Number of subjects: 214
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal lobe surgery
Number of subjects: 0
Study 15331972 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (general)
Number of subjects: 0
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal lobe surgery
Number of subjects: 0
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemispherotomy
Number of subjects: 0
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery
Number of subjects: 0
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Corpus callosotomy
Number of subjects: 0
Study 15331972 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple subpial transection
Number of subjects: 0
Study 11318982 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 1138
Study 9152566 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 200 micrograms once daily
Number of subjects: 45
Study 9152566 — intervention group
Group type: COMPARATOR
Intervention: Astemizole 10 mg once daily
Number of subjects: 45
Study 9152566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 8432221 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Protein Diet (LPD) at 0.6 g.kg‐1.day‐1
Number of subjects: 30
Study 8432221 — intervention group
Group type: COMPARATOR
Intervention: Usual Protein Diet (UPD)
Number of subjects: 30
Study 3321657 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-DHE
Number of subjects: 147290
Study 30541015 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive enteral nutrition (EEN)
Number of subjects: 19
Study 30541015 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids (CS)
Number of subjects: 19
Study 29353543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 66
Study 29353543 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational material)
Number of subjects: 66
Study 25775225 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) - standard single session
Number of subjects: 217
Study 25775225 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) - intensive 9-session model
Number of subjects: 217
Study 25775225 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient group treatment (both MI groups)
Number of subjects: 217
Study 23982800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 I.U.
Number of subjects: 305
Study 23982800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 1,000 I.U.
Number of subjects: 305
Study 23982800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 23982800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 1,000 I.U. (overweight participants)
Number of subjects: 305
Study 23982800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 I.U. and 1,000 I.U.
Number of subjects: 305
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical coniotomy
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Quicktrach II (cuffed device)
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Portex-Crico-Kit (cuffed device)
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: TracheoQuick (non-cuffed device)
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Airfree (non-cuffed device)
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Quicktrach I (non-cuffed device)
Number of subjects: 20
Study 22526742 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral intravenous cannula (non-cuffed device)
Number of subjects: 20
Study 20067607 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (maximum daily dose of 150 mg)
Number of subjects: 0
Study 20067607 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (maximum daily dose of 3000 mg)
Number of subjects: 0
Study 20067607 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac and Acetaminophen (both groups)
Number of subjects: 0
Study 17851566 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C9 genotype‐adjusted algorithms
Number of subjects: 191
Study 17851566 — intervention group
Group type: COMPARATOR
Intervention: Warfarin by a validated algorithm
Number of subjects: 191
Study 15982192 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom/Nebulizer Education Intervention (SNEI)
Number of subjects: 221
Study 15982192 — intervention group
Group type: COMPARATOR
Intervention: Standard Asthma Education (SAE)
Number of subjects: 221
Study 12794711 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (HAART)
Number of subjects: 43
Study 12794711 — intervention group
Group type: COMPARATOR
Intervention: Double therapy with reverse transcriptase inhibitors
Number of subjects: 43
Study 10575565 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b combined with ribavirin (1000 mg/day)
Number of subjects: 52
Study 10575565 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b alone
Number of subjects: 52
Study 8934367 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (40-50% maximal oxygen uptake)
Number of subjects: 18
Study 8934367 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (70-80% maximal oxygen uptake)
Number of subjects: 18
Study 8934367 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 18
Study 1884563 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate adjuvant chemotherapy
Number of subjects: 0
Study 1884563 — intervention group
Group type: COMPARATOR
Intervention: Observation without adjuvant treatment (Control)
Number of subjects: 0
Study 6355230 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy
Number of subjects: 24
Study 6355230 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 24
Study 30273549 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured ADL retraining during PTA plus TAU
Number of subjects: 104
Study 30273549 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 104
Study 28369875 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactoferrin with vitamin E and zinc (n = 82)
Number of subjects: 168
Study 28369875 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 82)
Number of subjects: 168
Study 26822579 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorvida Internet-based self-help program
Number of subjects: 0
Study 26822579 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual/waitlist (CAU/WL) control group
Number of subjects: 0
Study 25173668 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate, full-body photo
Number of subjects: 0
Study 25173668 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo modified to make them appear thinner than usual
Number of subjects: 0
Study 25173668 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo modified to make them appear heavier than usual
Number of subjects: 0
Study 25173668 — intervention group
Group type: COMPARATOR
Intervention: No photo of themselves
Number of subjects: 0
Study 25173668 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait body checking
Number of subjects: 0
Study 25173668 — intervention group
Group type: EXPERIMENTAL
Intervention: Body parts checking
Number of subjects: 0
Study 21985609 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem alone (5 mg)
Number of subjects: 0
Study 21985609 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem after pretreatment with fluvoxamine (5 mg zolpidem + 100 mg fluvoxamine)
Number of subjects: 0
Study 20807867 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical arnica cream
Number of subjects: 53
Study 20807867 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 53
Study 17145204 — intervention group
Group type: EXPERIMENTAL
Intervention: OPANA ER (oxymorphone extended release)
Number of subjects: 250
Study 17145204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 16137356 — intervention group
Group type: EXPERIMENTAL
Intervention: Right atrium lactate concentration ([Lac]ra)
Number of subjects: 45
Study 16137356 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery lactate concentration ([Lac]pa)
Number of subjects: 45
Study 16137356 — intervention group
Group type: EXPERIMENTAL
Intervention: Right atrium oxygen saturation (SraO2)
Number of subjects: 45
Study 16137356 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery oxygen saturation (SpaO2)
Number of subjects: 45
Study 16137356 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta[Lac] (change in lactate concentration)
Number of subjects: 45
Study 15267190 — intervention group
Group type: EXPERIMENTAL
Intervention: ROM (rifampicin 600 mg + ofloxacin 400 mg + minocycline 100 mg)
Number of subjects: 32
Study 15267190 — intervention group
Group type: COMPARATOR
Intervention: Standard WHO/MDT-PB six months' regimen
Number of subjects: 32
Study 10586091 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 in association with antiretroviral therapy (ART)
Number of subjects: 0
Study 10586091 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2/ART
Number of subjects: 0
Study 10586091 — intervention group
Group type: COMPARATOR
Intervention: IL-2
Number of subjects: 0
Study 8762699 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks)
Number of subjects: 90
Study 8762699 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in patients with Chagas' disease
Number of subjects: 90
Study 8762699 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in idiopathic patients
Number of subjects: 90
Study 8762699 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in ischemic and hypertensive patients
Number of subjects: 90
Study 1924656 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Blood Glucose Awareness Training (BGAT)
Number of subjects: 39
Study 1924656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Blood Glucose Awareness Training (BGAT)
Number of subjects: 39
Study 1924656 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study 6682669 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline monotherapy
Number of subjects: 29
Study 6682669 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoconazole nitrate (300 mg/day and 600 mg/day for 14 days)
Number of subjects: 29
Study 31318821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-emotional intervention (5 sessions, 60 to 90 minutes each, held twice a week)
Number of subjects: 100
Study 29370892 — intervention group
Group type: EXPERIMENTAL
Intervention: SILA (single incision laparoscopic appendectomy)
Number of subjects: 80
Study 29370892 — intervention group
Group type: COMPARATOR
Intervention: LA (conventional laparoscopy using three trocars)
Number of subjects: 80
Study 26449338 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg morphine intravenously
Number of subjects: 24
Study 26449338 — intervention group
Group type: COMPARATOR
Intervention: 180 mg ticagrelor
Number of subjects: 24
Study 26449338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 25584463 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 23870811 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg)
Number of subjects: 145
Study 23870811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 20658442 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine 1 g iv after each HD session for 12 weeks
Number of subjects: 10
Study 18076732 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-assisted technique (corn seed oil injection) - Group B
Number of subjects: 510
Study 18076732 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water method - Group C
Number of subjects: 510
Study 18076732 — intervention group
Group type: COMPARATOR
Intervention: Standard lubricating method (water-soluble jelly) - Group A (Control)
Number of subjects: 510
Study 17697220 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal midazolam (0.2 mg x kg(‐1))
Number of subjects: 179
Study 17697220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 12677618 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm rescue cuff
Number of subjects: 10
Study 11077390 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated cold stimulation of root areas
Number of subjects: 16
Study 11077390 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric testing of the root
Number of subjects: 16